Evidence map›Paper›PMID 35426258›Full record

ArticleAnnals of clinical and translational neurology2022

LINC00667 regulates MPP

Xinlong Huo, Lisong Wang, Jiahui Shao, Chenhang Zhou, Xiaowei Ying, Jinhua Zhao, Xinchun Jin

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xinlong HuoDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.
Lisong WangDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.
Jiahui ShaoDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.
Chenhang ZhouDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.
Xiaowei YingDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.
Jinhua ZhaoDepartment of Neurosurgery, The First People's Hospital of Xianyang, Xianyang, Shaanxi, 712000, China.
Xinchun JinDepartment of Neurology, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China.ORCID 0000-0003-3725-308X
The First People's Hospital of Wenling · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveParkinson's disease (PD), also known as paralysis tremor, is a chronic disease of the central nervous system. It has been reported that hepatocyte nuclear factor 4 alpha (HNF4A) is upregulated in PD, but its specific function has not been well explored.

methodsWe established an in vitro PD model in SH-SY5Y cells stimulated with 1-methyl-4-phenylpyridinium (MPP

resultsThe results revealed that depletion of HNF4A suppressed cell cytotoxicity and apoptosis caused by MPP

conclusionOur study first proved LINC00667, miR-34c-5p, and HNF4A constructed a positive feedback loop in MPP

Indexed as

MicroRNAsParkinson DiseaseRNA, Long Noncoding1-Methyl-4-phenylpyridiniumApoptosisHumans1-Methyl-4-phenylpyridiniumMicroRNAsRNA, Long Noncoding

Identifiers

PMID35426258
PMCPMC9082386
OpenAlexW4223988589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.